Back
EyePoint Pharmaceuticals Vs. Avidity Biosciences Industry Stock Comparison
Sell
33
EYPT
EyePoint Pharmaceuticals
Last Price:
$6.23
Seasonality Move:
16.96%
Sell
35
RNA
Avidity Biosciences
Last Price:
$32.10
Seasonality Move:
0%
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
-
The current EyePoint Pharmaceuticals [EYPT] share price is $6.34. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
EYPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $33.30. The Score for RNA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $6.34Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $33.30The current trend is relatively stagnant and RNA is experiencing buying pressure, which is a positive indicator for future bullish movement.
EYPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 45.37 | Sell |
Chaikin Money Flow: | -580139 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6 - 6.88) | Sell |
Bollinger Bands (100): | (6.36 - 9.76) | Sell |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.1 | Buy |
Relative Strength Index (14 RSI): | 56.39 | Buy |
Chaikin Money Flow: | 908474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.61 - 32.47) | Buy |
Bollinger Bands (100): | (29 - 41.56) | Sell |
EYPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.38 | Sell |
20-day SMA: | 6.48 | Sell |
50-day SMA: | 6.94 | Sell |
200-day SMA: | 8.5 | Sell |
8-day EMA: | 6.39 | Sell |
20-day EMA: | 6.52 | Sell |
50-day EMA: | 6.95 | Sell |
200-day EMA: | 9.12 | Sell |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.78 | Buy |
20-day SMA: | 30.71 | Buy |
50-day SMA: | 31.15 | Buy |
200-day SMA: | 38.72 | Sell |
8-day EMA: | 31.66 | Buy |
20-day EMA: | 31.36 | Buy |
50-day EMA: | 32.09 | Buy |
200-day EMA: | 33.87 | Sell |
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.10 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.96 per share, and a decrease next year of $0.48 per share.
EyePoint Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |